Wesley W. Choi

Associate

Wesley Choi is an associate in the Transactions Practice group in the firm’s San Francisco office, and is a member of the Innovative Technology, Health Care and Life Sciences sectors. She focuses her practice on advising emerging growth and startup companies, venture capital, private equity and other investors on entity formation, equity financings, buyouts, dispositions and general corporate counseling matters.

Wesley has represented a wide range of emerging growth companies and their investors in venture capital, growth equity and other financings, mergers, acquisitions and other corporate matters.

Wesley has also led various pro bono initiatives in the areas of immigration, election law, as well as nonprofit incorporation and governance.

Languages

  • Korean
05 January 2024 Deals and Wins

Foley Represents TDK Ventures as Lead Investor in Series A Funding Round for Faction Technology

Foley & Lardner LLP represented TDK Ventures as the lead investor in the Series A financing for driverless-technology developer Faction Technology.
04 January 2024 Deals and Wins

Foley Represents Envisioning Partners as Lead Investor in Series A Funding for Dimensional Energy

Foley & Lardner LLP represented Envisioning Partners as the lead investor in the Series A financing for Dimensional Energy, a global leader in carbon utilization technology, Sustainable Aviation Fuel production, and advanced carbon emissions-derived fuels and materials.
30 October 2023 Deals and Wins

Foley Represents True North in Minority Investment in iLink Digital

Foley & Lardner LLP acted as international legal counsel to True North, an India-based private equity firm, in its investment of $75 million for a minority stake in iLink Digital, a leading provider of digital transformation solutions.
27 September 2023 Deals and Wins

Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension

Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million Series B funding extension for ReCode Therapeutics.
31 August 2023 Deals and Wins

Foley Represents Altis Movement Technologies in Sale of Groundbreaking Human Motion Capture Assets

Foley & Lardner LLP represented Altis Movement Technologies in the sale of their groundbreaking human motion capture assets to Academy Medtech Ventures. Altis is a human kinematics AI and computer vision company responsible for the first Movement Operating System, Movement OS.
25 August 2023 Deals and Wins

Foley Represents Riverwood Capital as Lead Investor in $110M Growth Round for SpyCloud

Foley & Lardner LLP recently represented Riverwood Capital as lead investor in the $110 million growth round of primary and secondary capital for SpyCloud, a cybersecurity platform that operationalizes identity analytics to automate the protection of digital identities.